Header Logo

Connection

BRYAN BURT to Pleural Neoplasms

Back to Details
This is a "connection" page, showing publications BRYAN BURT has written about Pleural Neoplasms.
BRYAN BURT
Connection Strength
10.011
Pleural Neoplasms
  1. Ad-SGE-DKK3 Gene Therapy Overcomes Resistance to Immune Checkpoint Blockade in Pleural Mesothelioma. Clin Cancer Res. 2025 Jul 01; 31(13):2639-2654.
    View in: PubMed
    Score: 0.815
  2. A Phase II Window of Opportunity Study of Neoadjuvant PD-L1 versus PD-L1 plus CTLA-4 Blockade for Patients with Malignant Pleural Mesothelioma. Clin Cancer Res. 2023 02 01; 29(3):548-559.
    View in: PubMed
    Score: 0.690
  3. Checkpoint blockade in unresectable pleural mesothelioma: Event horizon for multimodal therapy. J Thorac Cardiovasc Surg. 2023 01; 165(1):364-368.
    View in: PubMed
    Score: 0.643
  4. Diagnostic Laparoscopy Improves Staging of Malignant Pleural Mesothelioma With Routine Positron Emission Tomography Imaging. Ann Thorac Surg. 2021 11; 112(5):1568-1574.
    View in: PubMed
    Score: 0.594
  5. Prognostic Role of Programmed Cell Death 1 Ligand 1 in Resectable Pleural Mesothelioma. Ann Thorac Surg. 2021 11; 112(5):1575-1583.
    View in: PubMed
    Score: 0.593
  6. Preoperative prediction of unresectability in malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 2020 06; 159(6):2512-2520.e1.
    View in: PubMed
    Score: 0.553
  7. To slay a dragon: Timing of chemotherapy in resectable pleural mesothelioma. J Thorac Cardiovasc Surg. 2019 02; 157(2):767-768.
    View in: PubMed
    Score: 0.514
  8. A Phase I Trial of Surgical Resection and Intraoperative Hyperthermic Cisplatin and Gemcitabine for Pleural Mesothelioma. J Thorac Oncol. 2018 09; 13(9):1400-1409.
    View in: PubMed
    Score: 0.497
  9. Comprehensive immunoproteogenomic analyses of malignant pleural mesothelioma. JCI Insight. 2018 04 05; 3(7).
    View in: PubMed
    Score: 0.494
  10. Therapeutic R2 resection for pleural mesothelioma. J Thorac Cardiovasc Surg. 2018 06; 155(6):2734-2735.
    View in: PubMed
    Score: 0.488
  11. Soluble Mesothelin-Related Peptides to Monitor Recurrence After Resection of Pleural Mesothelioma. Ann Thorac Surg. 2017 Nov; 104(5):1679-1687.
    View in: PubMed
    Score: 0.476
  12. Invited Commentary. Ann Thorac Surg. 2015 Nov; 100(5):1874.
    View in: PubMed
    Score: 0.417
  13. CTLA4 blockade in patients with malignant mesothelioma. Lancet Respir Med. 2015 Apr; 3(4):261-3.
    View in: PubMed
    Score: 0.400
  14. Malignant pleural mesothelioma and the Society of Thoracic Surgeons Database: an analysis of surgical morbidity and mortality. J Thorac Cardiovasc Surg. 2014 Jul; 148(1):30-5.
    View in: PubMed
    Score: 0.373
  15. Clinical indications and results after chest wall resection for recurrent mesothelioma. J Thorac Cardiovasc Surg. 2013 Dec; 146(6):1373-9; discussion 1379-80.
    View in: PubMed
    Score: 0.362
  16. Expression of interleukin-4 receptor alpha in human pleural mesothelioma is associated with poor survival and promotion of tumor inflammation. Clin Cancer Res. 2012 Mar 15; 18(6):1568-77.
    View in: PubMed
    Score: 0.321
  17. Circulating and tumor-infiltrating myeloid cells predict survival in human pleural mesothelioma. Cancer. 2011 Nov 15; 117(22):5234-44.
    View in: PubMed
    Score: 0.305
  18. Current Surgical Perspectives for Pleural Mesothelioma. J Natl Compr Canc Netw. 2026 Aug; 24(8).
    View in: PubMed
    Score: 0.220
  19. Loss of tumor suppressor NF2 mediates resistance to CAR T cell and anti-PD-1 therapy: Strategies to restore immunotherapy sensitivity. Med. 2026 Jul 10; 7(7):101149.
    View in: PubMed
    Score: 0.217
  20. The Society of Thoracic Surgeons 2026 Expert Consensus on the Multimodal Treatment of Pleural Mesothelioma. Ann Thorac Surg. 2026 07; 122(1):3-21.
    View in: PubMed
    Score: 0.216
  21. Soluble mesothelin-related peptide as a prognosticator in pleural mesothelioma patients receiving checkpoint immunotherapy. J Thorac Cardiovasc Surg. 2025 04; 169(4):1082-1095.e4.
    View in: PubMed
    Score: 0.194
  22. Pleurectomy and decortication are associated with better survival for bicavitary cytoreductive surgery for mesothelioma compared with extrapleural pneumonectomy. J Thorac Cardiovasc Surg. 2023 05; 165(5):1722-1730.
    View in: PubMed
    Score: 0.171
  23. A combination of intrinsic and extrinsic features improves prognostic prediction in malignant pleural mesothelioma. Br J Cancer. 2022 11; 127(9):1691-1700.
    View in: PubMed
    Score: 0.167
  24. Inhibition of Cyclin Dependent Kinase 4/6 Overcomes Primary Resistance to Programmed Cell Death 1 Blockade in Malignant Mesothelioma. Ann Thorac Surg. 2022 11; 114(5):1842-1852.
    View in: PubMed
    Score: 0.157
  25. Pleurectomy and decortication for metastatic renal cell carcinoma. J Thorac Cardiovasc Surg. 2015 Jul; 150(1):e3-5.
    View in: PubMed
    Score: 0.101
  26. Radiologic Considerations and Standardization of Malignant Pleural Mesothelioma Imaging Within Clinical Trials: Consensus Statement from the NCI Thoracic Malignancy Steering Committee - International Association for the Study of Lung Cancer - Mesothelioma Applied Research Foundation Clinical Trials Planning Meeting. J Thorac Oncol. 2019 10; 14(10):1718-1731.
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.